Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2013 1
2014 1
2015 2
2017 1
2018 1
2020 2
2021 7
2022 3
2023 3

Text availability

Article attribute

Article type

Publication date

Search Results

15 results

Results by year

Filters applied: . Clear all
Page 1
A New Practical Decision Rule to Better Differentiate BI-RADS 3 or 4 Breast Masses on Breast Ultrasound.
Pfob A, Barr RG, Duda V, Büsch C, Bruckner T, Spratte J, Nees J, Togawa R, Ho C, Fastner S, Riedel F, Schaefgen B, Hennigs A, Sohn C, Heil J, Golatta M. Pfob A, et al. J Ultrasound Med. 2022 Feb;41(2):427-436. doi: 10.1002/jum.15722. Epub 2021 May 4. J Ultrasound Med. 2022. PMID: 33942358
However, there is little information regarding which BI-RADS descriptors are most strongly associated with malignancy, to better distinguish BI-RADS 3 (follow-up imaging) and 4 (diagnostic biopsy) breast masses. ...Specificity was 44% versus 22-83%, re …
However, there is little information regarding which BI-RADS descriptors are most strongly associated with malignancy, to bett …
Outcomes of Return to Routine Screening for BI-RADS 3 Lesions Detected at Supplemental Automated Whole-Breast Ultrasound in Women With Dense Breasts: A Prospective Study.
Barr RG, DeSivestri A, Golatta M. Barr RG, et al. AJR Am J Roentgenol. 2021 Dec;217(6):1313-1321. doi: 10.2214/AJR.21.26180. Epub 2021 Jul 14. AJR Am J Roentgenol. 2021. PMID: 34259039
ABUS was interpreted as BI-RADS 1, 2, 3, or 0. Return to routine screening was recommended for ABUS BI-RADS 1, 2, or 3. ...A total of 2257 women (mean age, 58.0 11.2 [SD] years) were included. Supplemental ABUS was scored as BI-RADS 1 in …
ABUS was interpreted as BI-RADS 1, 2, 3, or 0. Return to routine screening was recommended for ABUS BI-RADS 1, 2 …
Potential of Lesion-to-Fat Elasticity Ratio Measured by Shear Wave Elastography to Reduce Benign Biopsies in BI-RADS 4 Breast Lesions.
Togawa R, Pfob A, Büsch C, Alwafai Z, Balleyguier C, Clevert DA, Duda V, Fastner S, Goncalo M, Gomez C, Gruber I, Hahn M, Hennigs A, Kapetas P, Nees J, Ohlinger R, Riedel F, Rutten M, Schäfgen B, Stieber A, Tozaki M, Wojcinski S, Rauch G, Heil J, Barr R, Golatta M. Togawa R, et al. J Ultrasound Med. 2023 Feb 15. doi: 10.1002/jum.16192. Online ahead of print. J Ultrasound Med. 2023. PMID: 36789976
METHODS: This was a secondary analysis of an international diagnostic multicenter trial (NCT02638935). Data from 1288 women with breast lesions categorized as BI-RADS 3 and 4a-c by conventional B-mode ultrasound were analyzed, whereby the focus was placed on differe …
METHODS: This was a secondary analysis of an international diagnostic multicenter trial (NCT02638935). Data from 1288 women with breast lesi …
WFUMB guidelines and recommendations for clinical use of ultrasound elastography: Part 2: breast.
Barr RG, Nakashima K, Amy D, Cosgrove D, Farrokh A, Schafer F, Bamber JC, Castera L, Choi BI, Chou YH, Dietrich CF, Ding H, Ferraioli G, Filice C, Friedrich-Rust M, Hall TJ, Nightingale KR, Palmeri ML, Shiina T, Suzuki S, Sporea I, Wilson S, Kudo M. Barr RG, et al. Ultrasound Med Biol. 2015 May;41(5):1148-60. doi: 10.1016/j.ultrasmedbio.2015.03.008. Epub 2015 Mar 18. Ultrasound Med Biol. 2015. PMID: 25795620 Free article. Review.
The relationship between the various techniques is discussed, and recommended interpretation based on a BI-RADS-like malignancy probability scale is provided. This document is intended to be used as a reference and to guide clinical users in a practical way....
The relationship between the various techniques is discussed, and recommended interpretation based on a BI-RADS-like malignanc …
The potential of combined shear wave and strain elastography to reduce unnecessary biopsies in breast cancer diagnostics - An international, multicentre trial.
Golatta M, Pfob A, Büsch C, Bruckner T, Alwafai Z, Balleyguier C, Clevert DA, Duda V, Goncalo M, Gruber I, Hahn M, Kapetas P, Ohlinger R, Rutten M, Togawa R, Tozaki M, Wojcinski S, Rauch G, Heil J, Barr RG. Golatta M, et al. Eur J Cancer. 2022 Jan;161:1-9. doi: 10.1016/j.ejca.2021.11.005. Epub 2021 Dec 5. Eur J Cancer. 2022. PMID: 34879299
METHODS: We report the secondary results of a prospective, multicentre, international trial (NCT02638935). The trial enrolled 1288 women with BI-RADS 3 to 4c breast masses on conventional B-mode breast ultrasound. ...Malignancies in the new BI-RADS 3 c …
METHODS: We report the secondary results of a prospective, multicentre, international trial (NCT02638935). The trial enrolled 1288 women wit …
Probably benign lesions at screening breast US in a population with elevated risk: prevalence and rate of malignancy in the ACRIN 6666 trial.
Barr RG, Zhang Z, Cormack JB, Mendelson EB, Berg WA. Barr RG, et al. Radiology. 2013 Dec;269(3):701-12. doi: 10.1148/radiol.13122829. Epub 2013 Oct 28. Radiology. 2013. PMID: 23962417 Free PMC article.
The number of new BI-RADS category 3 lesions decreased with year 2-3 screening, but the percentage of new BI-RADS category 3 lesions was stable at 26.4% (506 of 1920 lesions), 23.6% (142 of 601 lesions), and 24.6% (97 of 395 lesions), respectively. Of …
The number of new BI-RADS category 3 lesions decreased with year 2-3 screening, but the percentage of new BI-RADS …
Improved Breast 2D SWE Algorithm to Eliminate False-Negative Cases.
Barr RG, Engel A, Kim S, Tran P, De Silvestri A. Barr RG, et al. Invest Radiol. 2023 Mar 13. doi: 10.1097/RLI.0000000000000972. Online ahead of print. Invest Radiol. 2023. PMID: 36939607
The new 2D-SWE algorithm significantly increases the sensitivity and negative predictive value in characterizing breast lesions as benign or malignant and allows for downgrading all BI-RADS 4 lesions....
The new 2D-SWE algorithm significantly increases the sensitivity and negative predictive value in characterizing breast lesions as benign or …
Evaluation of the FUSION-X-US-II prototype to combine automated breast ultrasound and tomosynthesis.
Schäfgen B, Juskic M, Radicke M, Hertel M, Barr R, Pfob A, Togawa R, Nees J, von Au A, Fastner S, Harcos A, Gomez C, Stieber A, Riedel F, Hennigs A, Sohn C, Heil J, Golatta M. Schäfgen B, et al. Eur Radiol. 2021 Jun;31(6):3712-3720. doi: 10.1007/s00330-020-07573-3. Epub 2020 Dec 12. Eur Radiol. 2021. PMID: 33313983 Free PMC article.
The tomosynthesis and ABUS images of the prototype were interpreted independently from the clinical standard by a breast diagnostics specialist. Any detected lesion was classified using BI-RADS scores, and results of the standard clinical routine workup (gold standa …
The tomosynthesis and ABUS images of the prototype were interpreted independently from the clinical standard by a breast diagnostics special …
Diagnostic Accuracy of Shear-Wave Elastography for Breast Lesion Characterization in Women: A Systematic Review and Meta-Analysis.
Pillai A, Voruganti T, Barr R, Langdon J. Pillai A, et al. J Am Coll Radiol. 2022 May;19(5):625-634.e0. doi: 10.1016/j.jacr.2022.02.022. Epub 2022 Mar 28. J Am Coll Radiol. 2022. PMID: 35358483
Using the resulting likelihood ratios, SWE may prove beneficial in downgrading BI-RADS 4a or upgrading BI-RADS 3 lesions. However, current society guidelines do not provide definitive recommendations regarding the use of SWE and its counterpart strain …
Using the resulting likelihood ratios, SWE may prove beneficial in downgrading BI-RADS 4a or upgrading BI-RADS 3 …
The Potential of Shear Wave Elastography to Reduce Unnecessary Biopsies in Breast Cancer Diagnosis: An International, Diagnostic, Multicenter Trial.
Golatta M, Pfob A, Büsch C, Bruckner T, Alwafai Z, Balleyguier C, Clevert DA, Duda V, Goncalo M, Gruber I, Hahn M, Kapetas P, Ohlinger R, Rutten M, Tozaki M, Wojcinski S, Rauch G, Heil J, Barr RG. Golatta M, et al. Ultraschall Med. 2023 Apr;44(2):162-168. doi: 10.1055/a-1543-6156. Epub 2021 Aug 23. Ultraschall Med. 2023. PMID: 34425600 English.
Re-classifying BI-RADS 4a patients with a SWE cutoff of 2.55 m/s resulted in 1.98 % (11 of 556) undetected malignancies and a reduction of 24.24 % (375 vs. 495) of unnecessary biopsies. CONCLUSION: A SWE value below 2.55 m/s for BI-RADS 4a lesions coul …
Re-classifying BI-RADS 4a patients with a SWE cutoff of 2.55 m/s resulted in 1.98 % (11 of 556) undetected malignancies and a …
15 results